- en: <!--yml
  id: totrans-split-0
  prefs: []
  type: TYPE_NORMAL
  zh: <!--yml
- en: 'category: 未分类'
  id: totrans-split-1
  prefs: []
  type: TYPE_NORMAL
  zh: 'category: 未分类'
- en: 'date: 2024-05-27 14:45:09'
  id: totrans-split-2
  prefs: []
  type: TYPE_NORMAL
  zh: 'date: 2024-05-27 14:45:09'
- en: -->
  id: totrans-split-3
  prefs: []
  type: TYPE_NORMAL
  zh: -->
- en: 'mRNA vaccines: let''s eradicate herpes, cure cancer, and be sick a whole lot
    less'
  id: totrans-split-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: mRNA 疫苗：让我们根除疱疹，治愈癌症，减少生病的次数
- en: 来源：[https://bessstillman.substack.com/p/mrna-vaccines-lets-be-sick-a-whole](https://bessstillman.substack.com/p/mrna-vaccines-lets-be-sick-a-whole)
  id: totrans-split-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 来源：[https://bessstillman.substack.com/p/mrna-vaccines-lets-be-sick-a-whole](https://bessstillman.substack.com/p/mrna-vaccines-lets-be-sick-a-whole)
- en: '***Is there a healthcare topic you’d like to see covered, or a health question
    you need answered? Leave a comment or send me a message and the next article may
    be written especially for you!***'
  id: totrans-split-6
  prefs: []
  type: TYPE_NORMAL
  zh: '***有没有你想看到的健康话题，或者你需要回答的健康问题？留下评论或发信息给我，也许下一篇文章就专门为你写！***'
- en: 'I ended “[The unexpected gift of Long COVIDLong COVID: could new research treat
    chronic fatigue syndromes and cure cancer?](https://bessstillman.substack.com/p/the-unexpected-gift-of-covid)”
    by saying that even though Post-Acute-Infectious-Syndromes (PAISes) like Long
    COVID can be caused by a wide variety of pathogens (viruses, bacteria, fungi,
    parasites, bad vibes from that annoying girl you knew in college), we probably
    don’t have to treat the pathogen itself to treat the PAIS. Research shows significant
    overlap in the pathways causing chronic symptoms, even if the initial triggering
    pathogen is unknown. It’s likely that multiple pathogens are responsible for triggering
    the same PAIS symptoms. If, say, 10 different bacteria, 15 viruses, and 2 fungal
    infections all trigger a biochemical pathway that causes a leaky blood-brain barrier,
    which, in turn, causes the symptom of “brain fog,” then one treatment for “blood-brain
    barrier problems” might work well.'
  id: totrans-split-7
  prefs: []
  type: TYPE_NORMAL
  zh: 我在“[长期COVID的意外礼物——新研究是否能治疗慢性疲劳综合症和治愈癌症？](https://bessstillman.substack.com/p/the-unexpected-gift-of-covid)”中说，即使像长期COVID这样的后急性传染综合征（PAISes）可以由多种病原体（病毒、细菌、真菌、寄生虫，还有你大学时认识的讨厌女孩发出的不好的气氛）引起，我们可能不必治疗病原体本身来治疗PAIS。研究显示，导致慢性症状的路径有显著重叠，即使最初触发路径的病原体未知。很可能多种病原体都负责触发相同的PAIS症状。例如，10种不同的细菌、15种病毒和2种真菌感染都可能触发导致脑雾的生化通路，那么一种“血脑屏障问题”的治疗方法可能效果很好。
- en: As with Long COVID, pathogens can trigger pathways that *stay triggered* even
    after the body has defeated the pathogen. For example, you get COVID, then your
    body eliminates COVID, but the symptoms of Long COVID persist because the initial
    infection triggered pathways that lead to fatigue, brain fog and heart rhythm
    abnormalities. The virus is gone, but the PAIS, annoyingly, remains.
  id: totrans-split-8
  prefs: []
  type: TYPE_NORMAL
  zh: 就像长期COVID一样，病原体可以触发路径，即使身体已经击败了病原体，这些路径仍然会保持触发状态。例如，你感染了COVID，然后你的身体清除了COVID，但长期COVID的症状仍然存在，因为最初的感染触发了导致疲劳、脑雾和心律不齐的路径。病毒已经消失，但令人恼火的是，PAIS仍然存在。
- en: Creating drugs that address the *pathway* leading to “leaky blood-brain-barrier
    problems” rather than *the individual pathogen* triggering the pathway (which
    could potentially be triggered by hundreds of pathogens!) will likely mean more
    treatments, faster, for more people, especially if a common blood biomarker—a
    chemical in the blood that signals that a certain pathway has been triggered—can
    be identified and tested for.
  id: totrans-split-9
  prefs: []
  type: TYPE_NORMAL
  zh: 创造药物，解决导致“漏血脑屏障问题”的*通路*，而不是*触发该通路的单个病原体*（可能会被数百种病原体触发！），很可能意味着更多人更快地得到治疗，尤其是如果可以识别和测试一种常见的血液生物标志物——血液中的某种化学物质，表明某个通路已被触发。
- en: Anything that helps more people get treatment faster is good for human flourishing,
    but being able to use single therapies against multiple disease types is especially
    important because [the FDA is so painfully slow](https://jakeseliger.com/2024/01/29/the-dead-and-dying-at-the-gates-of-oncology-clinical-trials/),
    and so indifferent to human suffering. It takes, on average, [eight](https://www.fda.gov/drugs/investigational-new-drug-ind-application/drug-development-and-review-definitions#:~:text=FDA%20estimates%20that%20it%20takes,clinical%20trials%20using%20human%20subjects.)
    *[years](https://www.fda.gov/drugs/investigational-new-drug-ind-application/drug-development-and-review-definitions#:~:text=FDA%20estimates%20that%20it%20takes,clinical%20trials%20using%20human%20subjects.)*
    to get a new drug through clinical trials.
  id: totrans-split-10
  prefs: []
  type: TYPE_NORMAL
  zh: 任何有助于更多人更快获得治疗的方法对人类的繁荣都是有益的，但能够针对多种疾病类型使用单一疗法尤为重要，因为[美国食品药品监督管理局（FDA）处理速度极其缓慢](https://jakeseliger.com/2024/01/29/the-dead-and-dying-at-the-gates-of-oncology-clinical-trials/)，对人类苦难漠不关心。根据平均数据，新药通常需要[八年](https://www.fda.gov/drugs/investigational-new-drug-ind-application/drug-development-and-review-definitions#:~:text=FDA%20estimates%20that%20it%20takes,clinical%20trials%20using%20human%20subjects.)的时间通过临床试验。
- en: As I mentioned briefly at the end of part 1, the problem is that drugs treating
    pathways triggered by otherwise defeated pathogens won’t work if symptoms are
    caused by pathogens that actually remain in the body (otherwise known as "pathogenic
    persistence”).  Pathogenic persistence means that the body *can’t eliminate* the
    pathogen (the virus, bacteria, fungus or parasite) after becoming infected. Treating
    the pathways these pathogents triggermight help, but if you stop treating the
    pathway, symptoms are likely to come back, because the pathogen is still there.
    It’s like buying increasingly expensive presents for a girlfriend you want to
    marry, but who won’t commit to you. Maybe she seems temporarily more loving after
    you give her a fancy bauble, but until you break it off and pull the knife from
    your heart, you’re going to keep bleeding.
  id: totrans-split-11
  prefs: []
  type: TYPE_NORMAL
  zh: 正如我在第一部分结尾简要提到的那样，问题在于，如果症状是由实际仍然存在于体内的病原体引起的（也就是“病原体持久性”），那么治疗通常无法奏效。病原体持久性意味着身体*无法清除*感染后的病原体（病毒、细菌、真菌或寄生虫）。尽管可能有助于治疗这些病原体触发的病理过程，但如果停止治疗这些过程，症状很可能会复发，因为病原体仍然存在。这就像为了追求婚姻的女友而不断购买更昂贵的礼物，但她却不愿意与你承诺。也许在你给她一件华丽的宝贝后她会暂时显得更加亲切，但直到你彻底结束并从心中拔出这把刀，你仍将满身是血。
- en: 'Persistent viral infections are common (you probably have one right now) and
    the cost of persistent viral infections is high—and high in ways scientists and
    doctors didn’t appreciate for a long time. Some examples, as previously noted:'
  id: totrans-split-12
  prefs: []
  type: TYPE_NORMAL
  zh: 持久性病毒感染是常见的（您现在可能有一个），持久性病毒感染的代价高——科学家和医生长期以来并没有意识到这一点。一些例子，如先前提到的：
- en: '· **Epstein-Barr Virus** ([EBV) is a major risk factor in](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052849/#:~:text=EBV%20is%20linked%20to%20the,breast%20cancer%20(BC)%2034.)
    the development of multiple sclerosis ([30-fold increase in risk](https://www.nature.com/articles/s41582-023-00775-5#:~:text=Infection%20with%20EBV%20increases%20the,decades%20after%20the%20primary%20infection.)),
    lymphoma, and nasopharyngeal cancer. It may play a role in other cancers, such
    as [breast cancer](https://pubmed.ncbi.nlm.nih.gov/35741320/). Ninety-five percent
    of adults carry EBV. Epstein-Barr is sneaky. It actually encodes small RNAs (which
    are information the body uses to make proteins) that can inactivate genes that
    are stimulated by a normal immune response. This is similar to the way mRNA vaccines
    work: by introducing RNA into the body, so that cells can read the RNA, which
    teaches those cells how to make proteins, which then exert the desired effect.
    EBV is making its own RNA “vaccine” to exert the desired effect of evading the
    immune system.'
  id: totrans-split-13
  prefs: []
  type: TYPE_NORMAL
  zh: · **Epstein-Barr 病毒** ([EBV](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052849/#:~:text=EBV%20is%20linked%20to%20the,breast%20cancer%20(BC)%2034.)
    ) 是多发性硬化症 ([风险增加30倍](https://www.nature.com/articles/s41582-023-00775-5#:~:text=Infection%20with%20EBV%20increases%20the,decades%20after%20the%20primary%20infection.))、淋巴瘤和鼻咽癌发展的一个主要风险因素。它可能在其他癌症中起到作用，如[乳腺癌](https://pubmed.ncbi.nlm.nih.gov/35741320/)。九十五成的成年人携带EBV。埃普斯坦-巴尔病毒是狡猾的。它实际上编码了小RNA（这些是身体用来制造蛋白质的信息），可以失活受到正常免疫反应刺激的基因。这类似于mRNA疫苗的工作原理：通过将RNA引入体内，使细胞能够读取RNA，从而教导细胞如何制造蛋白质，进而产生所需的效果。EBV正在制造自己的RNA“疫苗”，以达到逃避免疫系统的目的。
- en: · **Human Papilloma Virus** (HPV) infections are implicated in cervical, anal,
    oral and genital cancers. Fortunately, [we have a vaccine](https://www.gardasil9.com/).
    Unfortunately, too few people get it.
  id: totrans-split-14
  prefs: []
  type: TYPE_NORMAL
  zh: '**人类乳头瘤病毒**（HPV）感染与宫颈、肛门、口腔和生殖癌有关。幸运的是，[我们有一种疫苗](https://www.gardasil9.com/)。不幸的是，接种这种疫苗的人数太少。'
- en: · **Herpes Simplex Virus** (HSV) [may play a major role in Alzheimer’s](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234998/).
    Up to 80% of adults have an HSV1 infection. HSV1 and HSV2 are poxviruses that
    live in nerves forever. Chicken Pox (varicella) is also a persistent poxvirus
    that lives in nerves. Reactivated varicella virus becomes a shingles rash.
  id: totrans-split-15
  prefs: []
  type: TYPE_NORMAL
  zh: '**单纯疱疹病毒**（HSV）[可能在阿尔茨海默病中起主要作用](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234998/)。多达
    80% 的成年人患有 HSV1 感染。HSV1 和 HSV2 是永久生活在神经中的痘病毒。水痘（水痘）也是在神经中持久存在的痘病毒。复活的水痘病毒会变成带状疱疹。'
- en: · **Lyme disease** may have a long tail of weird symptoms, and its [ability
    to hide](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC257809/#:~:text=The%20demonstration%20of%20B.,later%20stages%20of%20Lyme%20disease.)
    inside the cells lining blood vessels may help it evade the immune system and
    create a persistent infection. Tragically, [we had a working Lyme disease vaccine](https://thewalrus.ca/lyme-disease-vaccine/)
    that the company pulled due to anti-vaxxer hysteria.
  id: totrans-split-16
  prefs: []
  type: TYPE_NORMAL
  zh: '**莱姆病**可能有一系列奇怪的症状，并且它在血管内壁细胞中的[隐藏能力](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC257809/#:~:text=The%20demonstration%20of%20B.,later%20stages%20of%20Lyme%20disease.)有助于它逃避免疫系统并创建持久性感染。可悲的是，[我们曾有一个有效的莱姆病疫苗](https://thewalrus.ca/lyme-disease-vaccine/)，但由于反疫苗者的恐慌，公司撤回了该疫苗。'
- en: To address viral persistence, vaccines, especially [mRNA vaccines, are our best
    bet](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917162/) for speed and flexibility.
    Preventing infection in the first place is ideal, but vaccines can also help improve
    the response against an infection, thus reducing the risk of pathogenic persistence,
    or help to reduce the amount of pathogen that persists inside the body.
  id: totrans-split-17
  prefs: []
  type: TYPE_NORMAL
  zh: 要解决病毒持久感染问题，特别是 [mRNA 疫苗，是我们最好的选择](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917162/)，因为它们快速且灵活。预防感染是理想的，但疫苗也可以帮助改善对感染的反应，从而减少致病物持久性的风险，或者帮助减少体内持续存在的病原体数量。
- en: 'Consider how mRNA vaccines work: Messenger RNA (mRNA) is a molecule that contains
    instructions that tell cells how to make various proteins. Each protein has its
    own novel set of RNA instructions. All proteins made in a human body are built
    when a cell “reads” the RNA instructions.'
  id: totrans-split-18
  prefs: []
  type: TYPE_NORMAL
  zh: 考虑 mRNA 疫苗的工作原理：信使RNA（mRNA）是一种分子，其中包含指导细胞如何制造各种蛋白质的指令。每种蛋白质都有其独特的RNA指令集。人体中制造的所有蛋白质都是在细胞“读取”RNA指令时建造的。
- en: 'An mRNA vaccine synthesizes mRNA instructions in a lab using uniquely organized
    strands of just four building block chemicals called nucleotides: Adenine, Cytosine,
    Guanine and Uracil. Varying combinations of these four molecules can instruct
    the body to create basically any protein. These instructions are read inside a
    cell, and the protein is made by the cell.'
  id: totrans-split-19
  prefs: []
  type: TYPE_NORMAL
  zh: mRNA 疫苗在实验室中合成 mRNA 指令，使用四种称为核苷酸的基本化学物质：腺嘌呤、胞嘧啶、鸟嘌呤和尿嘧啶，这些化学物质的不同组合可以指导身体基本上制造任何蛋白质。这些指令在细胞内被读取，细胞制造蛋白质。
- en: RNA is fragile. So, like in the COVID mRNA vaccines, these instructions can
    be delivered in a protective fatty bubble called a “lipid nanoparticle.” Think
    of it like a balloon made of fatty acids, with the instructions nestled inside.
    Once injected, these lipid nanoparticles take the mRNA instructions into cells,
    where the fatty bubble degrades, mRNA instructions are released, and the cell’s
    machinery start to produce whatever protein the mRNA tells it to.
  id: totrans-split-20
  prefs: []
  type: TYPE_NORMAL
  zh: RNA 很脆弱。因此，就像在 COVID mRNA 疫苗中一样，这些指令可以在称为“脂质纳米粒子”的保护脂质泡泡中传递。可以将其想象成由脂肪酸制成的气球，里面包裹着指令。一旦注射，这些脂质纳米粒子将
    mRNA 指令带入细胞，脂质泡泡降解，释放 mRNA 指令，细胞的机器开始制造指令告诉它制造的蛋白质。
- en: For COVID, the mRNA instructed the cells to make the spike protein, which is
    found on the outside of the COVID virus. But we can make mRNA vaccines that teach
    a cell to make any protein that corresponds to a protein on a pathogen that doesn’t
    normally exist in the human body. Once the cells started making the spike protein,
    or any protein the body doesn’t normally use, the body’s immune system recognizes
    the protein as foreign, and mounts an immune response against it. This is how
    the body creates antibodies, which act like immune memory. The immune system mounts
    a response just as it would if that protein was introduced to the body by a pathogen,
    except with the vaccine, your body learns to recognize parts of the pathogen without
    ever being infected.
  id: totrans-split-21
  prefs: []
  type: TYPE_NORMAL
  zh: 对于COVID，mRNA指导细胞制造出位于COVID病毒外表面的刺突蛋白。但我们可以制造mRNA疫苗，教导细胞制造出任何与人体内正常不存在的病原体上蛋白质对应的蛋白质。一旦细胞开始制造刺突蛋白，或者任何身体不正常使用的蛋白质，免疫系统就会将其识别为外来物质，并对其产生免疫反应。这就是身体产生抗体的方式，其作用就像免疫记忆。免疫系统对这些蛋白质的反应，就像这些蛋白质是被病原体引入体内一样，只是通过疫苗，你的身体学会了识别病原体的部分，而没有真正感染。
- en: 'MRNA vaccines are faster, cheaper and more flexible to make than their traditional
    counterparts:'
  id: totrans-split-22
  prefs: []
  type: TYPE_NORMAL
  zh: MRNA疫苗的制造速度快、成本低、灵活性强，比传统疫苗更胜一筹：
- en: ·      Synthetic mRNA, the foundation of the vaccines, **can be designed and
    manufactured in a lab within days** of the sequencing of the genetic code of a
    pathogen’s target protein.
  id: totrans-split-23
  prefs: []
  type: TYPE_NORMAL
  zh: ·      人工合成的mRNA，作为疫苗的基础，在病原体目标蛋白质的基因序列测定后，**能够在实验室内几天内设计和制造**。
- en: ·      MRNA vaccines **don’t rely on growing large quantities of weakened virus
    or viral vectors**, which eases production.
  id: totrans-split-24
  prefs: []
  type: TYPE_NORMAL
  zh: ·      MRNA疫苗**不依赖于大量培养削弱病毒或病毒载体**，这简化了生产过程。
- en: '· **They’re flexible**: Since cell cultures (imagine test tubes filled with
    animal cells that are infected with a virus and used to grow large quantities
    of the virus ) aren’t necessary, and the mRNA instructions can be quickly synthesized
    in a lab, if there is a mutation in the virus, it’s much quicker and easier to
    create new mRNA vaccines. New mutations? Re-create the new target protein in the
    lab. mRNA vaccines are the Burger King of vaccines: you *can* have it your way.'
  id: totrans-split-25
  prefs: []
  type: TYPE_NORMAL
  zh: · **它们灵活**：因为不需要细胞培养（想象一下装满动物细胞、被病毒感染并用来大量生产病毒的试管），并且mRNA指令可以在实验室内快速合成，如果病毒发生突变，创建新的mRNA疫苗更快更容易。新的突变？在实验室重新创建新的靶标蛋白质。mRNA疫苗是疫苗的顶级选择：*你*可以按照*你*的方式来。
- en: · **MRNA vaccines can code for** ***multiple*** **protein targets** on a single
    virus, which means that they can better address resilient pathogens resistant
    to vaccine development, like herpes . Attacking multiple protein targets at once
    might create a more robust immune response. [MRNA vaccine trials for genital herpes](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695322/),
    which traditional vaccines have failed to prevent, [are currently underway with
    BioNTech](https://investors.biontech.de/news-releases/news-release-details/biontech-starts-phase-1-clinical-trial-prophylactic-herpes).
    That’s great news for prevention.
  id: totrans-split-26
  prefs: []
  type: TYPE_NORMAL
  zh: · **MRNA疫苗可以编码** ***多个*** **单一病毒上的蛋白靶标**，这意味着它们可以更好地应对像单纯疱疹这样对疫苗开发有抵抗力的强健病原体。同时攻击多个蛋白靶标可能会产生更强健的免疫反应。[用于生殖器疱疹的MRNA疫苗试验](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695322/)，传统疫苗未能预防，[目前已由BioNTech进行中](https://investors.biontech.de/news-releases/news-release-details/biontech-starts-phase-1-clinical-trial-prophylactic-herpes)。这对预防来说是个好消息。
- en: '**MRNA vaccines have the potential to prevent future infection from so many
    pathogens that plague us, but what about people who are already infected?**  [Eighty
    percent of American adults already have herpes](https://www.hopkinsmedicine.org/health/conditions-and-diseases/herpes-hsv1-and-hsv2#:~:text=Herpes%20infections%20are%20very%20common,U.S.%20age%2014%20to%2049.)
    virus type 1, and [95% of the adult population ages 35+ carry Epstein-Barr Virus
    (EBV](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415781/)). MRNA vaccines might
    act to modulate the body’s downstream response to a virus, even after infection.'
  id: totrans-split-27
  prefs: []
  type: TYPE_NORMAL
  zh: '**MRNA疫苗具有潜力预防我们身上困扰的许多病原体未来的感染，但已经感染的人怎么办？** [80%的美国成年人已感染单纯疱疹病毒](https://www.hopkinsmedicine.org/health/conditions-and-diseases/herpes-hsv1-and-hsv2#:~:text=Herpes%20infections%20are%20very%20common,U.S.%20age%2014%20to%2049.)
    类型1，而[95%的35岁以上成年人群携带艾普斯坦-巴尔病毒（EBV）](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415781/)。MRNA疫苗可能在感染后调节身体对病毒的下游反应。'
- en: '[HPV is a good proof of concept](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045378/)
    regarding the possibility that vaccines can decrease negative downstream effects
    of an infection, even if it’s too late to prevent an infection. Studies show that
    HPV-vaccine naive patients who are HPV positive, with early precancerous cervical
    changes (“CIN1”), and who receive the HPV vaccine after diagnosis, have a decreased
    progression of precancerous changes (CIN2,3). HPV vaccination provides a pathway
    for both infection prevention and decreased effects of persistent infection. That
    the vaccine seems able to head off cancer is important in light of how many women
    and men don’t get the vaccine when they should. Still, between 2012-19, cervical
    cancer incidence in women in their 20s decreased by 65%, despite poor vaccine
    uptake. Preventing HPV decreases cancer risk, but so does, to a lesser extent,
    receiving the vaccine after infection. That’s great news for women who didn’t
    receive the vaccine due to fear or age. And it’s great news for men, since HPV
    can cause oral, neck, penile, and anal cancers. HPV decreases the amount of fun
    in the world and the vaccine increases it. Science rules!'
  id: totrans-split-28
  prefs: []
  type: TYPE_NORMAL
  zh: '[HPV是一个很好的概念验证](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045378/)，即疫苗可以减少感染的负面下游效应，即使已经太迟无法预防感染。研究表明，HPV疫苗未接种过的HPV阳性患者，早期子宫颈病变（“CIN1”），在诊断后接种HPV疫苗，减少了前癌性变（CIN2,3）的进展。HPV疫苗为预防感染和减少持续感染效应提供了一条路径。疫苗似乎能够防止癌症的发生，这在许多应该接种疫苗的妇女未接种疫苗时尤为重要。尽管疫苗接受率不高，2012-19年间，二十多岁妇女的宫颈癌发病率减少了65%。预防HPV可以减少癌症风险，而接种疫苗后感染也在较小程度上降低了这种风险。对于因恐惧或年龄原因未接种疫苗的女性来说，这是个好消息。对于男性来说也是一样，因为HPV可能导致口腔、颈部、阴茎和肛门癌。HPV减少了世界的乐趣，而疫苗增加了它。科学在这里统治！'
- en: 'Quick aside: Right now, the HPV vaccine is “approved” up to age 46, but that’s
    mostly based on arbitrary age cutoffs chosen for the initial studies and the belief
    that a person needs to be vaccinated before they’re exposed for benefit. Nothing
    indicates that the HPV vaccine is dangerous for people over 46, and the age cutoff
    was chosen based on the frankly wrongheaded and naive assumptions about the sex
    lives of women (and men) who are married or over a certain age. Assuming that
    age or marital status will prevent someone from HPV exposure assumes that people
    are having less sex as they age, monogamous sex, and ignores the 107% uptick in
    STIs among patients over 55+ in the last decade. If you’re a human being who hasn’t
    had the HPV vaccine and you have ever been sexually active or are currently sexually
    active, or will be sexually active, get the series or a booster.'
  id: totrans-split-29
  prefs: []
  type: TYPE_NORMAL
  zh: 快速提一下：目前，HPV疫苗被“批准”使用到46岁，但这主要基于最初研究选择的任意年龄截止点和这样的信念，即一个人需要在暴露之前接种疫苗才能受益。没有任何证据表明HPV疫苗对46岁以上的人有危险，年龄截止点是基于对已婚或达到某个年龄的女性（和男性）性生活的错误和幼稚假设选择的。假设年龄或婚姻状态会阻止某人感染HPV是建立在人们随着年龄增长减少性生活、一夫一妻制性生活的假设之上，并忽略了过去十年55岁以上患者性传播疾病激增107%的事实。如果你是一个人类，没有接种过HPV疫苗，并且曾经有过性生活或目前正在进行性生活，或将来会进行性生活，请接种HPV疫苗系列或接种加强剂。
- en: Sometimes. Patients have been found to be COVID positive for months after their
    initial infection on antigen tests, which are looking for active infection, and
    not antibody tests, which look for past infection. Viral persistence increases
    the risk of Long COVID.
  id: totrans-split-30
  prefs: []
  type: TYPE_NORMAL
  zh: 有时候，患者在初次感染后的数月内仍然可以通过抗原检测检测为COVID阳性，这些检测是寻找活动感染的，而不是寻找过去感染的抗体检测。病毒持续感染增加了长期COVID的风险。
- en: '[COVID vaccination appears to confer a 40-60% reduction in Long COVID](https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00414-9/fulltext).
    Studies suggest that vaccines might have both protective and [therapeutic effects](https://www.ijidonline.com/article/S1201-9712(23)00720-8/fulltext)
    on LLong COVID. Therapeutic effects, by which I mean giving a person with Long
    COVID a COVID vaccine and seeing their Long COVID symptoms decrease, makes me
    wonder if viral persistence is a bigger overall problem in COVID than we’ve realized.'
  id: totrans-split-31
  prefs: []
  type: TYPE_NORMAL
  zh: '[COVID疫苗接种似乎可以减少长期COVID的发生率40-60%](https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00414-9/fulltext)。研究表明，疫苗可能对长期COVID具有保护作用和[治疗效果](https://www.ijidonline.com/article/S1201-9712(23)00720-8/fulltext)。所谓的治疗效果是指给长期COVID患者接种COVID疫苗后，观察其长期COVID症状减轻，这使我怀疑病毒持续感染在COVID中是否是一个更大的问题，这一点我们之前并未意识到。'
- en: Vaccine skepticism hurts in terms of uptake (thanks, [Wakefield](https://www.nature.com/articles/d41586-020-02989-9)—he’s
    the guy who made up data that first spread the “vaccines cause autism” meme).
    The initial conversation around COVID vaccination revolved around preventing deaths,
    but it’s clear that, as a society, we’ve decided that COVID deaths are allowable
    background noise. But, beyond death itself, there are also tremendous human misery
    and socioeconomic costs from a huge uptick in chronic illness and disability.
  id: totrans-split-32
  prefs: []
  type: TYPE_NORMAL
  zh: 疫苗怀疑论在接受程度上造成了伤害（谢谢，[韦克菲尔德](https://www.nature.com/articles/d41586-020-02989-9)
    — 他就是首次传播“疫苗导致自闭症”的谣言的那个人）。关于 COVID 疫苗的最初对话围绕预防死亡展开，但很明显，作为一个社会，我们已经决定 COVID 死亡是可以接受的背景噪音。但是，除了死亡本身，还有来自慢性疾病和残疾大幅增加的巨大人类痛苦和社会经济成本。
- en: '[Share](https://bessstillman.substack.com/p/mrna-vaccines-lets-be-sick-a-whole?utm_source=substack&utm_medium=email&utm_content=share&action=share)'
  id: totrans-split-33
  prefs: []
  type: TYPE_NORMAL
  zh: '[分享](https://bessstillman.substack.com/p/mrna-vaccines-lets-be-sick-a-whole?utm_source=substack&utm_medium=email&utm_content=share&action=share)'
- en: Think of mRNA vaccines as injectable instructions that turn your body’s cells
    into factories that can create any protein for which mRNA instructions can be
    built. Because a researcher can theoretically make mRNA instructions for any protein,
    mRNA vaccines aren’t only useful against pathogens; they can be used to teach
    the body to mount an immune response to *any foreign protein that you want destroy*,
    including proteins on cancer cells—called neoantigens—caused by mutated tumor
    DNA.
  id: totrans-split-34
  prefs: []
  type: TYPE_NORMAL
  zh: 将 mRNA 疫苗视为注射式指令，将您体内的细胞转变为可以制造任何可以建立 mRNA 指令的蛋白质的工厂。因为研究人员理论上可以为任何蛋白质制造 mRNA
    指令， mRNA 疫苗不仅对抗病原体有用；它们还可以用于教导免疫系统对 *任何你想要消灭的外源蛋白质*（包括由突变的肿瘤 DNA 导致的癌细胞上的蛋白质，称为新抗原）产生免疫反应。
- en: '**To create an mRNA cancer vaccine**, a patient’s tumor is biopsied to identify
    unique target mutations —> mRNA correlating to mutations is synthesized and injected
    into the patient —> the patient’s cells create the targeted protein —> the creation
    of foreign proteins stimulates the immune system and teaches it how to recognize
    the target protein —> The immune system (especially T cells) search for this target
    protein and destroy the cancer cells to which it’s attached. Cancer cells are
    notorious at finding ways to hide from the immune system, but the mRNA vaccine
    is like giving the immune system magnifying glasses. The mRNA cancer vaccine production
    process is similar to that of producing a COVID vaccine, except, instead of a
    spike protein, the target is the neoantigen. Thanks to the speed and flexibility
    of mRNA vaccines, everyone with cancer could have a personalized cancer vaccine
    that’ll have significantly fewer side effects than chemo or radiation.'
  id: totrans-split-35
  prefs: []
  type: TYPE_NORMAL
  zh: '**为了创建 mRNA 癌症疫苗**，需要从患者的肿瘤中取样，以识别独特的靶点突变 —> 合成与突变相关的 mRNA 并注入患者体内 —> 患者的细胞生成靶向蛋白质
    —> 外源蛋白质的生成刺激免疫系统，并教导其如何识别目标蛋白质 —> 免疫系统（特别是 T 细胞）寻找并摧毁与之结合的癌细胞。癌细胞以隐藏免疫系统的方式而臭名昭著，但
    mRNA 疫苗就像给予免疫系统放大镜一样。与生产 COVID 疫苗类似， mRNA 癌症疫苗的生产过程，除了针对刺突蛋白外，还针对新抗原进行。由于 mRNA
    疫苗的速度和灵活性，每个癌症患者都可以获得个性化的癌症疫苗，其副作用明显少于化疗或放疗。'
- en: 'R&D for the mRNA COVID vaccines has already hastened the development of mRNA
    cancer vaccines. Foundational mRNA research focused on cancer: Ozlem Tureci, MD,
    co-founder and CMO of BioNTech, performed research in mRNA-based cancer therapies
    and also led the clinical development for “Project Lightspeed” to develop an mRNA
    COVID vaccine. Drew Weissman’s lab at U Penn created the platform for nucleoside-modified
    mRNA-lipid nanoparticle vaccines, which Pfizer, BioNTech, and Moderna used for
    COVID vaccine development. Weissman’s lab also works on ways to use mRNA vaccines
    in bone marrow stem cells and T cells.'
  id: totrans-split-36
  prefs: []
  type: TYPE_NORMAL
  zh: 研发 mRNA COVID 疫苗已经加速了 mRNA 癌症疫苗的开发。关于癌症的基础性 mRNA 研究：BioNTech 的联合创始人兼首席医疗官 Ozlem
    Tureci 博士进行了 mRNA 基因治疗癌症的研究，并带领“光速计划”开发 mRNA COVID 疫苗。位于宾夕法尼亚大学的 Drew Weissman
    实验室创建了核苷酸修饰 mRNA-脂质纳米颗粒疫苗平台，供 Pfizer、BioNTech 和 Moderna 用于 COVID 疫苗开发。Weissman
    实验室还致力于研究如何在骨髓干细胞和 T 细胞中应用 mRNA 疫苗。
- en: The most exciting mRNA cancer vaccine study Is currently [Moderna’s 4157 vaccine](https://trials.modernatx.com/study/?id=mRNA-4157-P201)
    for melanoma, lung cancer, head and neck cancer, and probably others. Patients
    with high-risk stage III/IV melanoma had a complete resection of their tumors
    followed by mRNA-4157 and the immune checkpoint inhibitor Keytruda, or Keytruda
    and placebo injection. MRNA-4157 and Keytruda reduced the risk of recurrence or
    death by 49%, and the risk of distant metastasis or death was reduced by 62% compared
    to Keytruda alone. This year, Moderna is expanding clinical trials to patients
    with non-small cell lung cancer. Phase 1 studies also showed extremely [promising
    results in notoriously difficult-to-treat head and neck cancer](https://www.fiercebiotech.com/biotech/moderna-s-keytruda-combo-misses-colorectal-cancer-as-it-shows-promise-head-and-neck),
    with two of the ten patients having complete resolution of their tumors, and 40%
    having a significant, if partial, response. Late-stage and recurrent head and
    neck cancer
  id: totrans-split-37
  prefs: []
  type: TYPE_NORMAL
  zh: 目前最令人振奋的mRNA癌症疫苗研究是[Moderna的4157疫苗](https://trials.modernatx.com/study/?id=mRNA-4157-P201)，适用于黑色素瘤、肺癌、头颈癌，以及可能还有其他类型。高危III/IV期黑色素瘤患者经过完全切除肿瘤后接受mRNA-4157及免疫检查点抑制剂Keytruda，或者Keytruda及安慰剂注射。相比单独使用Keytruda，mRNA-4157和Keytruda降低了复发或死亡风险49%，远处转移或死亡风险降低了62%。今年，Moderna正在扩展临床试验，适用于非小细胞肺癌患者。1期研究还显示在治疗难度极大的头颈癌中表现出极为[有希望的结果](https://www.fiercebiotech.com/biotech/moderna-s-keytruda-combo-misses-colorectal-cancer-as-it-shows-promise-head-and-neck)，十名患者中有两名完全消退肿瘤，40%患者有显著的部分反应。晚期和复发性头颈癌
- en: Bespoke immunotherapy tailored to a patient’s exact tumor will change the way
    cancer is treated. Immunotherapies don’t yet work for all cancers. Moderna’s mRNA-4157
    fell short for colorectal cancer, but there are other companies like [Genentech](https://www.mskcc.org/news/can-mrna-vaccines-fight-pancreatic-cancer-msk-clinical-researchers-are-trying-find-out)
    also working on colorectal cancer. Genentech is currently running a phase 2 open-label
    study for pancreatic cancer. FDA requirements are slowing down progress—Moderna
    apparently can’t get approval until they have their factory ready. Delay means
    more cancer patients will be added to the invisible graveyard), but progress is
    at least being made. COVID showed us how fast we can progress, and I hope that
    researchers keep up the pace in applying mRNA vaccines across pathogens and cancers.
  id: totrans-split-38
  prefs: []
  type: TYPE_NORMAL
  zh: 定制免疫疗法，根据患者确切的肿瘤类型，将改变癌症治疗方式。免疫疗法目前尚未适用于所有癌症。[现代](https://www.mskcc.org/news/can-mrna-vaccines-fight-pancreatic-cancer-msk-clinical-researchers-are-trying-find-out)的mRNA-4157在结肠直肠癌治疗中表现不佳，但还有像[基因泰克](https://www.mskcc.org/news/can-mrna-vaccines-fight-pancreatic-cancer-msk-clinical-researchers-are-trying-find-out)这样的其他公司也在进行结肠直肠癌的研究。基因泰克目前正在进行胰腺癌的2期开放标签研究。FDA的要求正在拖延进展——显然现代不能在工厂准备好之前获得批准。延迟意味着更多癌症患者将被加入看不见的坟场，但至少还在取得进展。COVID展示了我们在短时间内能够取得的进展速度，我希望研究人员在跨越病原体和癌症应用mRNA疫苗的速度上保持这种步伐。
- en: '**The need for both mRNA technology and speed is deeply personal**, and not
    just because I’m a physician who wants to offer her patients better treatments:
    my husband Jake has recurrent metastatic head and neck cancer. He’s being kept
    alive by a clinical trial drug, [petosemtamab](https://jakeseliger.com/2023/12/07/tentative-fluttering-optimism-the-surprising-hot-r-d-ferment-in-head-and-neck-cancer-treatment/),
    but there isn’t a standard-of-care option that can cure him. Squamous cell carcinoma
    recurrence and metastases is a death sentence, unless, maybe, his immune system
    can be trained to mount a targeted, sustained response. Only about 20 – 30% of
    head and neck cancer patients like Jake respond to Keytruda alone or Keytruda
    combined with chemo. Moderna’s mRNA-4157 vaccine might change the whole head and
    neck cancer game. There’s rumor that Moderna might expand their phase 2 studies
    to include additional cancer types this year, and, if anyone from Moderna’s reading
    this, we’re in Arizona, close to the site where you ran the phase 1 head and neck
    study, and Jake will be the first patient to sign up.'
  id: totrans-split-39
  prefs: []
  type: TYPE_NORMAL
  zh: '**mRNA技术和速度的需求对我来说深具个人意义**，这不仅因为我是一名希望为患者提供更好治疗的医生：我的丈夫Jake患有复发性转移性头颈癌。他目前靠一种临床试验药物[petosemtamab](https://jakeseliger.com/2023/12/07/tentative-fluttering-optimism-the-surprising-hot-r-d-ferment-in-head-and-neck-cancer-treatment/)维持生命，但没有标准治疗可以治愈他。鳞状细胞癌的复发和转移是一种死亡判决，除非他的免疫系统能够被训练产生有针对性的持续反应。大约只有20-30%的像Jake这样的头颈癌患者对Keytruda单药或与化疗联合治疗有反应。Moderna的mRNA-4157疫苗可能会改变整个头颈癌的治疗方式。有传言称Moderna可能会在今年扩展他们的二期研究，包括其他癌症类型，如果Moderna的任何人看到这篇文章，我们在亚利桑那州，靠近你们进行第一阶段头颈癌研究的地点，Jake将是第一个签约的病人。'
- en: At the beginning of the pandemic, I feared I’d bring home COVID from the hospital
    and accidentally kill Jake. Now, COVID and mRNA development might be the impetus
    for the treatment that keeps him alive.
  id: totrans-split-40
  prefs: []
  type: TYPE_NORMAL
  zh: 在疫情初期，我担心从医院带回COVID，不小心害死了Jake。现在，COVID和mRNA的开发可能会成为让他活下去的治疗的动力。
- en: In the way wars accelerate technological and medical developments, so, too do
    pandemics, which are themselves a kind of war. Four years in, physicians have
    learned a lot about human suffering. Now, I’m hopeful that the ongoing lessons
    of COVID might change the way we perceive, diagnose, and treat chronic illness,
    PAISess, and cancer. The momentum we’ve built is precious, and proof that science
    and research *can* happen quickly when adequately motivated. I hope we keep up
    the pace, even as the FDA slows progress and We’ve paid dearly for COVID’s gifts.
    Let’s not squander them.
  id: totrans-split-41
  prefs: []
  type: TYPE_NORMAL
  zh: 就像战争加速技术和医学发展一样，疫情也是一种战争。四年来，医生们对人类苦难有了很多了解。现在，我对COVID的持续教训能否改变我们对慢性病、PAISess和癌症的认知、诊断和治疗方式充满希望。我们所积累的势头是宝贵的，也证明了在充分激励时，科学和研究是可以迅速进行的。我希望即使FDA放缓进展，我们也能保持这种步伐，并且我们为COVID的恩赐付出了昂贵的代价，让我们不要浪费它们。
- en: '*If you’ve gotten this far, [consider the Go Fund Me](https://www.gofundme.com/f/help-the-fight-against-cancer-with-jake-s)
    that’s funding my husband Jake’s [ongoing cancer treatment](https://jakeseliger.com/2023/07/22/i-am-dying-of-squamous-cell-carcinoma-and-the-treatments-that-might-save-me-are-just-out-of-reach/).*'
  id: totrans-split-42
  prefs: []
  type: TYPE_NORMAL
  zh: '*如果你看到这里，请考虑[Go Fund Me](https://www.gofundme.com/f/help-the-fight-against-cancer-with-jake-s)的支持，该平台正在资助我丈夫Jake的[持续癌症治疗](https://jakeseliger.com/2023/07/22/i-am-dying-of-squamous-cell-carcinoma-and-the-treatments-that-might-save-me-are-just-out-of-reach/)。*'
- en: '[Support Jake''s Cancer Treatments](https://www.gofundme.com/f/help-the-fight-against-cancer-with-jake-s)'
  id: totrans-split-43
  prefs: []
  type: TYPE_NORMAL
  zh: '[支持Jake的癌症治疗](https://www.gofundme.com/f/help-the-fight-against-cancer-with-jake-s)'
- en: '* * *'
  id: totrans-split-44
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
- en: ZAP! Take that, you filthy tumor!
  id: totrans-split-45
  prefs: []
  type: TYPE_NORMAL
  zh: ZAP！看你，可恶的肿瘤！
- en: '* * *'
  id: totrans-split-46
  prefs: []
  type: TYPE_NORMAL
  zh: '* * *'
